T1	Outcomes 844 899	12-month changes in spine and hip bone mineral density.
T2	Outcomes 928 1128	changes in markers of bone resorption (urine N-telopeptide cross-linked collagen type I) and formation (osteocalcin, N-terminal propeptide of type I procollagen, and bone-specific alkaline phosphatase
T3	Outcomes 1156 1176	bone mineral density